Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00912158
Other study ID # RICU, Assiut University 1
Secondary ID
Status Completed
Phase Phase 4
First received April 8, 2009
Last updated August 17, 2009
Start date October 2003
Est. completion date November 2007

Study information

Verified date August 2009
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority Egypt: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Cardiogenic pulmonary edema (CPE) is a common medical emergency and noninvasive ventilation (NIV) in addition to conventional medical treatment might be beneficial for patients with CPE.


Description:

To evaluate the effect of adding continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP) to standard medical therapy (ST) on intensive care unit (ICU) stay, hospital stay, mortality, need for endotracheal intubation, partial arterial O2 tension (PaO2), intrapulmonary shunt, alveolar-arterial (A-a) oxygen gradient, and cardiac output in patients admitted to the respiratory intensive care unit (ICU) or cardiac care unit (CCU) with acute CPE with gas exchange abnormalities and to evaluate the impact of heart failure type on the outcome of different therapeutic schedules.


Recruitment information / eligibility

Status Completed
Enrollment 129
Est. completion date November 2007
Est. primary completion date November 2007
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. CPE confirmed radiologically and/or clinically

2. Severe acute respiratory failure (partial arterial oxygen (PaO2)/Fraction of inspired oxygen (FIO2) less than 250)

3. Dyspnea of sudden onset with respiratory

4. Systolic blood pressure < 180 mmHg

Exclusion Criteria:

1. Immediate need for endotracheal intubation:

- Severe sensorial impairment

- Shock

- Ventricular arrhythmias,

- Life-threatening hypoxia (SpO2 [oxygen saturation as indicated by pulse oximetry] less than 80% with oxygen)

- Acute myocardial infarction necessitating thrombolysis

- Cardiac or respiratory arrest

2. Severe chronic renal failure

3. Pneumothorax.

4. Contraindication of non invasive ventilation (NIV)

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
standard therapy (ST)
standard medical therapy
Device:
CPAP
Non-invasive mechanical ventilation (CPAP)
BIPAP
Non-invasive mechanical ventilation (BIPAP)

Locations

Country Name City State
Egypt Assiut University Hospital Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (4)

Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Non-invasive ventilation in acute cardiogenic pulmonary oedema. Postgrad Med J. 2005 Oct;81(960):637-43. Review. — View Citation

Chadda K, Annane D, Hart N, Gajdos P, Raphaël JC, Lofaso F. Cardiac and respiratory effects of continuous positive airway pressure and noninvasive ventilation in acute cardiac pulmonary edema. Crit Care Med. 2002 Nov;30(11):2457-61. — View Citation

Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J; 3CPO Trialists. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med. 2008 Jul 10;359(2):142-51. doi: 10.1056/NEJMoa0707992. — View Citation

Vital FM, Saconato H, Ladeira MT, Sen A, Hawkes CA, Soares B, Burns KE, Atallah AN. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005351. doi: 10.1002/14651 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Patients Who Were Intubated During ICU Stay Yes
Secondary Arterial Blood Gases, Respiratory Rate, Blood Pressure, Cardiac Output ,Intrapulmonary Shunt, A-a Oxygen Gradient, Heart Rate, and Dyspnea Duration of Hospital and ICU Stay and Mortality Hospital stay Yes
See also
  Status Clinical Trial Phase
Recruiting NCT02874339 - High Flow Nasal Oxygen Versus VNI in Acute Hypercapnic Cardiogenic Pulmonary Edema N/A
Completed NCT00439075 - OUT-OF-HOSPITAL CPAP STUDY Phase 4
Completed NCT02653365 - Predictors of Non-invasive Ventilation Failure in Patients With Acute Cardiogenic Pulmonary Edema N/A
Completed NCT04014088 - Helmet CPAP vs Facemask CPAP in ACPE (hCPAP vs fCPAP) N/A
Completed NCT03883555 - High Flow Nasal Cannula Therapy for Early Management of Acute Hypercapnic Cardiogenic Pulmonary Edema in the Emergency Department